Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 32 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
LEFEVRE PHARMA from Fleurus, company number BE0831780443, closed financial year 2025 with a result of € 57,478 after tax. For that financial year LEFEVRE PHARMA recorded a gross margin of € 338,547 and equity of € 286,391. Compared with financial year 2024, the result moved from € 18,922 to € 57,478. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.
€ 286,391
▲ 25% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 57,478
▲ 204% vs 2024
Profit after tax over the fiscal year.
€ 2,247
▼ 93% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 265,931.
People and assets in 2025
3
Average over the fiscal year, from the social balance sheet.
€ 153,229
▲ 54% vs 2024
€ 51,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 67,333
▲ € 62,198 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 977,959
▼ 5% vs 2024
€ 107,213 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 188,908
▼ 23% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 72,801
▲ 71% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 204,190 | € 200,940 | € 231,677 | € 338,547 | ▲ 46% |
| Profit after taxes | € 53,447 | € 13,320 | € 18,922 | € 57,478 | ▲ 204% |
| Equity | € 221,671 | € 209,991 | € 228,913 | € 286,391 | ▲ 25% |
| Total debts | € 618,050 | € 837,293 | € 1,325,447 | € 1,240,589 | ▼ 6% |
| Cash | € 71,513 | € 53,009 | € 30,688 | € 2,247 | ▼ 93% |
| Land & buildings | € 550,653 | € 58,936 | € 325,345 | € 309,539 | ▼ 5% |
| Retained profit | € 201,211 | € 189,531 | € 208,453 | € 265,931 | ▲ 28% |
| Bank debt | € 521,743 | € 655,061 | € 1,030,226 | € 977,959 | ▼ 5% |
| Balance sheet total | € 839,721 | € 1,047,284 | € 1,554,360 | € 1,526,981 | ▼ 2% |
| Employees (FTE) | 2.2 | - | - | 3 |
By gross margin, LEFEVRE PHARMA ranks 1st of 4 companies with main activity “Detailhandel in farmaceutische producten” in Fleurus that publish figures (fiscal year 2025).
Key figures of LEFEVRE PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about LEFEVRE PHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to LEFEVRE PHARMA?
What happened at LEFEVRE PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 57,478 (▲ 204% vs 2024). Source: NBB ↗
- New establishment in Fleurus. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 53,447 profit in 2022 to € 57,478 profit in 2025.
Paid € 47,905 in corporate taxes since 2022.
Best year ever: 2025, with € 57,478 profit.
On average € 112,800 of value added per employee in 2025.
Establishments
Establishment units
Physical locations of this company
Route de Gosselies(WAN) 331
6220 Fleurus
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Fleurus
Same main activity (Detailhandel in farmaceutische producten), 3 active companies in Fleurus, largest first.
€ 157,537 gross margin · 2025
€ 116,058 gross margin · 2025
€ 81,694 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- LEFEVRE Marie-Odile Madeleine Patricia(fondateur) 100%
Details
- Company number
- 0831.780.443
- VAT number
- BE 0831.780.443
- Registered office
- Route de Gosselies(WAN) 331, 6220 Fleurus
- Names & denominations
- LEFEVRE PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 December 2010
- Peppol
- Active · Active since 2 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten